BCL2 and amyotrophic lateral sclerosis: ALS iPSCs have been established and ALS iPSC-derived MNs show pathological characteristics of this disease: diminished neurite length, protein aggregation, and an enhanced apoptosis [13–16] that is reversible by over-expression of Bcl-2 [17].